Navigation Links
Link Between Infection And Heart Disease

Within the last few years, there has been a lot of research on the potential link between infection and heart disease. Now, a new study shows that the more infections you have throughout your life, the more likely// you are to die from heart disease. The researchers, from the Johannes Gutenberg University in Mainz, Germany, looked at more than 570 people with heart disease. They tested their blood for the common bacteria and viruses to see if they had evidence of past infection or exposure.

They found that the number of infections was directly related to dying from heart disease or stroke. People with 3 or less of these infections had a death rate of 3%. The death rate jumped to 10%, however, for those exposed to 4 or 5 infections, and to 15% for those with 6 or more infections. In people with advanced hardening of the arteries, 20% of those who tested positive for at least 6 infections died during the study period compared to just 7% of those with 3 or less infections.

"We showed a significant association between the number of infections to which someone has been exposed and the extent of hardening of the arteries in the heart, neck, and legs," says study leader Hans J. Rupprecht, MD. He points out that the people already had heart disease at the beginning of the study. Thus, it's hard to prove the exact nature of the association between infection and heart disease.

According to the researchres, the infection/heart disease link is probably a result of immune reactions. Exposure to multiple infections causes inflammation of the blood vessels, which, over time, can lead to hardening of the arteries and heart disease.
'"/>




Page: 1

Related medicine news :

1. Prescription Drug Use Varies Widely Between States
2. Wait Between Pregnancies
3. Link Between Migraines and Behavioral Disorders
4. Link Between Obesity and Behavior in Kids
5. Link Between Mothers Depression and Violence in Children
6. Link Between Alcohol and Decrease in Brain Size
7. Link Between Musculoskeletal Pain and Vitamin D Deficiency
8. Link Between Hyperglycemia & Hospital Mortality
9. Link Between Alcohol Consumption And Cardiovascular Disease
10. Understanding The Link Between Hormone Replacement and Respiratory Disease
11. The Link Between Breast Cancer and Aborted Pregnancy Questioned
Post Your Comments:
(Date:5/16/2008)...INGTON, May 16 /PRNewswire-USNewswire/ -- As tropi... the Irrawaddy delta, survivors of,Cyclone Nargis ...ms. Many,survivors still need assistance, as expos...ing an increasingly dire situation., "The people ... to,recover from this disaster and get back on the...
(Date:5/16/2008)...peals for Funds Focus on Millions of Children Stil... U.S. Fund for UNICEF and The,Advertising Council ...omote,a series of national public service announce...ng Ben Stiller, Nicole Ritchie, Joel Madden, David...to help survivors of the,Myanmar cyclone. The Ad C...
(Date:5/16/2008)...ORT BEACH, Calif., May 16 /PRNewswire-FirstCall/ -... announced today the promotion of David,M. Boitano...ficer. "Dave,has made a tremendous contribution to...ur strong investment growth and diversification st...er $1 billion in accretive,investments for NHP, le...
(Date:5/16/2008)...DIEGO, May 16 /PRNewswire-FirstCall/ -- CryoCor, I...ed on the treatment of cardiac,arrhythmias, announ... of,CryoCor common stock filed a complaint in the ...of San Diego, naming as defendants each member of ...ton Scientific Corporation.,The complaint is style...
Breaking Medicine News(10 mins):Health News:Myanmar Cyclone Survivors Face New Challenges 2Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 2Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 3Health News:David M. Boitano Promoted to Senior Vice President 2Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 2Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 3Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 4
... U.S panel hearing that cheaper versions of biolog...h, Education, Labor and Pensions Committee is cons...rug Administration legal authority to approve alte...logic drugs after patents expire. Yet it has dra...
...n reported in a duck farm in Chonan, in central So...firmed as bird flu on Thursday//. The cause was id...It is the seventh bird flu outbreak since November...5N1 virus was the cause of the six previous outbre...
...ce new carbonated drinks fortified with vitamins a...g away from traditional soda drinks for their alle...68 billion-industry in the US. However consumers a...er, sparkling juices and green tea drinks, reporte...
...to celebrate the emancipation and empowerment of w...ice//. In addition to the distinction of being a g...ing Nepal's only graduate goddess. From 1987, when...was worshipped and revered throughout Nepal for ei...
Other Medicine News:Health News:Generic Biologics – U.S Panel Hearing Draws Mixed Response 2Health News:Nepal Gets Its First Graduate Goddess 2
(Date:5/15/2008)...Efficacy Clinical Data from Prostate, Colorectal a..., - Company to Hold Investor Event on Sun., June ...alif., May 15 /- Poniard,Ph...eutical company focused,on oncology, today announc...linical trials of picoplatin, in various tumor typ...
(Date:5/15/2008)..., N.J., May 15 /- Schering-...ncing the science and treatment of,chronic hepatit...ata from,several clinical studies with PEGINTRON(T...in, USP) combination therapy, as well as boceprevi... inhibitor, will be presented at,the 39th annual D...
(Date:5/15/2008)... Mich. and TOULOUSE, France, May 15 /...eld pharmaceutical company,developing HDL-related ...metabolic diseases, today announced that it has co...of the company,s lead product candidates.,CER-002 ...PAR),delta-specific agonist in development for the...
(Date:5/15/2008)... Md., May 15 /- Novavax, In...leted enrollment in the Phase I/IIa,study of its p...roximately,230 subjects. Favorable interim results... dose-escalation in 70 healthy adult volunteers, w...s suggested that the vaccine,is well tolerated and...
Breaking Medicine Technology:Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 2Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 3Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 4Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 7Cerenis Therapeutics Completes Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease 2Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial 2Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial 3Knee brace generates electricity from walking 3135 1Knee brace generates electricity from walking 3135 2Susan G Komen for the Cure 28R 29 Hosts Annual Affiliate Leadership Conference in Dallas 11369 1Susan G Komen for the Cure 28R 29 Hosts Annual Affiliate Leadership Conference in Dallas 11369 2Susan G Komen for the Cure 28R 29 Hosts Annual Affiliate Leadership Conference in Dallas 11369 3ORBIS International Announces the Death of the Honorable Oliver Foot President and Board Member 11364 1ORBIS International Announces the Death of the Honorable Oliver Foot President and Board Member 11364 2Gene variant predicts medication response in patients with alcohol dependence 11361 1Gene variant predicts medication response in patients with alcohol dependence 11361 2Gene variant predicts medication response in patients with alcohol dependence 11361 3
...2007,/PRNewswire-FirstCall/ -- Rigel Pharmaceutica... which is currently in ongoing,Phase 2 clinical tr...umatoid arthritis (RA) and lymphoma patients. R788... the activation of mast cells,macrophages and B-c... and tissue damage. , Rigel commenced an explorato...
...1, 2007 - A comparison of,the long-term economic o...mbined with symptom management versus symptom,mana... acetate,injection) was the most cost-effective tr...sclerosis (RRMS). The study provides,the first pha... of,multiple sclerosis (MS) therapies that include...
Other Medicine Technology:Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP,Rheumatoid Arthritis and Lymphoma 2Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP,Rheumatoid Arthritis and Lymphoma 3Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP,Rheumatoid Arthritis and Lymphoma 4First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone,Was More Cost-Effective Than Interferon Beta Therapies for,Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) 2First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone,Was More Cost-Effective Than Interferon Beta Therapies for,Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) 3First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone,Was More Cost-Effective Than Interferon Beta Therapies for,Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) 4First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone,Was More Cost-Effective Than Interferon Beta Therapies for,Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) 5First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone,Was More Cost-Effective Than Interferon Beta Therapies for,Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) 6
...Instruments incorporate a layered design unique in...nitored to prevent stray electrosurgical burns alo...n failure or capacitive coupling; a well-documente... into all AEM Instruments provides a neutral retur...
...Instruments incorporate a layered design unique in...nitored to prevent stray electrosurgical burns alo...n failure or capacitive coupling; a well-documente... into all AEM Instruments provides a neutral retur...
...Instruments incorporate a layered design unique in...nitored to prevent stray electrosurgical burns alo...n failure or capacitive coupling; a well-documente... into all AEM Instruments provides a neutral retur...
...Instruments incorporate a layered design unique in...nitored to prevent stray electrosurgical burns alo...n failure or capacitive coupling; a well-documente... into all AEM Instruments provides a neutral retur...
Medicine Products: